SYNH Syneos Health Inc

Price (delayed)

$72.05

Market cap

$7.39B

P/E Ratio

30.79

Dividend/share

N/A

EPS

$2.34

Enterprise value

$10.48B

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to ...

Highlights
Syneos Health's EPS has increased by 23% YoY and by 3.5% QoQ
The P/E is 23% below the last 4 quarters average of 39.0
Syneos Health's debt has increased by 4.2% QoQ
Syneos Health's equity has decreased by 3.3% from the previous quarter

Key stats

What are the main financial stats of SYNH
Market
Shares outstanding
102.58M
Market cap
$7.39B
Enterprise value
$10.48B
Valuations
Price to earnings (P/E)
30.79
Price to book (P/B)
2.27
Price to sales (P/S)
1.4
EV/EBIT
26.64
EV/EBITDA
16.55
EV/Sales
1.96
Earnings
Revenue
$5.34B
EBIT
$393.33M
EBITDA
$633.22M
Free cash flow
$324.94M
Per share
EPS
$2.34
Free cash flow per share
$3.13
Book value per share
$31.68
Revenue per share
$51.52
TBVPS
$24.62
Balance sheet
Total assets
$8.3B
Total liabilities
$5B
Debt
$3.21B
Equity
$3.3B
Working capital
$153.88M
Liquidity
Debt to equity
0.97
Current ratio
1.09
Quick ratio
1
Net debt/EBITDA
4.88
Margins
EBITDA margin
11.9%
Gross margin
23.3%
Net margin
4.5%
Operating margin
7.5%
Efficiency
Return on assets
3%
Return on equity
7.3%
Return on invested capital
10.3%
Return on capital employed
6%
Return on sales
7.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SYNH stock price

How has the Syneos Health stock price performed over time
Intraday
3.06%
1 week
12.04%
1 month
2.11%
1 year
-16.52%
YTD
-29.83%
QTD
-10.99%

Financial performance

How have Syneos Health's revenue and profit performed over time
Revenue
$5.34B
Gross profit
$1.25B
Operating income
$402.16M
Net income
$242.28M
Gross margin
23.3%
Net margin
4.5%
The company's operating income rose by 32% YoY and by 3.3% QoQ
The net income is up by 22% year-on-year and by 3.2% since the previous quarter
SYNH's revenue is up by 20% YoY and by 2.4% from the previous quarter
Syneos Health's gross profit has increased by 20% YoY and by 2.3% QoQ

Growth

What is Syneos Health's growth rate over time

Valuation

What is Syneos Health stock price valuation
P/E
30.79
P/B
2.27
P/S
1.4
EV/EBIT
26.64
EV/EBITDA
16.55
EV/Sales
1.96
Syneos Health's EPS has increased by 23% YoY and by 3.5% QoQ
The P/E is 23% below the last 4 quarters average of 39.0
SYNH's price to book (P/B) is 21% lower than its last 4 quarters average of 2.8 and 3.9% lower than its 5-year quarterly average of 2.3
Syneos Health's equity has decreased by 3.3% from the previous quarter
The price to sales (P/S) is 28% lower than the last 4 quarters average of 1.9 and 9% lower than the 5-year quarterly average of 1.5
SYNH's revenue is up by 20% YoY and by 2.4% from the previous quarter

Efficiency

How efficient is Syneos Health business performance
SYNH's ROIC is up by 21% YoY but it is down by 2.8% from the previous quarter
Syneos Health's return on equity has increased by 16% YoY and by 2.8% QoQ
Syneos Health's return on assets has increased by 15% YoY and by 3.4% QoQ
Syneos Health's return on sales has increased by 10% YoY but it has decreased by 2.6% QoQ

Dividends

What is SYNH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SYNH.

Financial health

How did Syneos Health financials performed over time
The total assets is 66% higher than the total liabilities
SYNH's total liabilities is up by 6% year-on-year and by 3.7% since the previous quarter
The total assets rose by 4.4% YoY
Syneos Health's debt is 2.9% lower than its equity
SYNH's debt to equity is up by 8% since the previous quarter
Syneos Health's debt has increased by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.